Vaccine News and Research

Latest Vaccine News and Research

Trimeris, Roche collaborate to commercialize FUZEON product

Trimeris, Inc., announced today that the Company and its partner, F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc., have entered into an agreement relieving Trimeris of any obligation to repay certain deferred marketing expenses.

28 Sep 2010

Mucosis collaborates with PATH to pursue use of Mimopath technology in diarrhea vaccines

Dutch biotechnology company Mucosis B.V. announced today that it has entered into a collaboration agreement with the global health nonprofit organization PATH to pursue the use of the company's Mimopath technology in oral vaccines to prevent and treat severe diarrhea.

28 Sep 2010

Suicide rates high among middle-aged people

The suicide rate for middle-aged people - a group considered relatively protected from suicide and with historically stable suicide rates - took an upward jump between 1999 and 2005, according to research by sociologists Ellen Idler of Emory University and Julie Phillips of Rutgers University.

28 Sep 2010

Clinical study results for patient-specific vaccine therapy to treat metastatic melanoma announced

Hoag Memorial Hospital Presbyterian recently announced encouraging clinical study results for patient-specific vaccine therapy to treat metastatic melanoma. The study is ongoing, but the report concludes that patient-specific vaccines can sometimes induce durable complete regression of progressing soft-tissue melanoma metastases, as demonstrated in one particular patient who participated in the trial.

28 Sep 2010

AASLD, TFAH report calls for action to help identify Americans living with HBV, HCV

The American Association for the Study of Liver Diseases and the Trust for America's Health issued a new report today calling for action to be taken to transform how the country deals with viral hepatitis – to help identify millions of Americans who know they are living with chronic forms of hepatitis B and C and to assure access to treatment for all who need it, to prevent even more Americans from becoming infected.

28 Sep 2010

Many adults skip vaccines because of costs

The New York Times' Patient Money column examines the importance of vaccines for adults.

28 Sep 2010

IAVI investigators awarded grant to examine antibodies that neutralize HIV virus

A team of investigators headed by International AIDS Vaccine Initiative Investigator Pascal Poignard has been awarded a major grant from the National Institute of Allergy and Infectious Diseases of the US National Institutes of Health to investigate the biological mechanisms underlying the generation of broadly neutralizing antibodies by HIV positive individuals.

28 Sep 2010

BMC physicians receive $3M NIH grant to identify TB biomarkers

Boston Medical Center has been chosen to lead an investigation aimed at developing novel approaches to prevent tuberculosis. Jerrold J. Ellner, MD, chief of the section of infectious diseases at BMC and professor of medicine at the Boston University School of Medicine, a renowned expert in the field, will serve as principal investigator on the five-year, $3 million grant funded by the National Institutes of Health.

28 Sep 2010

Sanofi Pasteur signs agreement to acquire VaxDesign

Sanofi Pasteur, the vaccines division of the sanofi-aventis Group announced today that it has signed a binding agreement for the acquisition of VaxDesign, a privately held U.S. biotechnology company, based in Orlando, Florida, that develops, manufactures and markets in vitro models of the human immune system.

28 Sep 2010

BMC physicians to lead international research collaboration to curb infectious diseases

Boston Medical Center (BMC) has been chosen to lead an investigation aimed at developing novel approaches to prevent tuberculosis (TB). Jerrold J. Ellner, MD, chief of the section of infectious diseases at BMC and professor of medicine at the Boston University School of Medicine (BUSM), a renowned expert in the field, will serve as principal investigator (PI) on the five-year, $3 million grant funded by the National Institutes of Health (NIH).

27 Sep 2010

Condoms can prevent transmission of herpes simplex virus 2: Study

Condom use is associated with a reduced risk of contracting herpes simplex virus 2, according to a report based on pooled analysis of data from previous studies in the July 13 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

27 Sep 2010

Researchers identify cellular/molecular defect in T cell regulatory pathway

Researchers at Columbia University Medical Center have identified a defect in the T cell regulatory pathway which normally controls autoreactive T cells that attack the body's own tissues and organs. A majority of people with Type 1 diabetes who were tested in the study were found to have the newly-identified cellular/molecular defect, and the researchers were able to successfully correct the defect in-vitro.

27 Sep 2010

ARTES acquires ANAVAX virus-like particle technology from Select Vaccines

ARTES Biotechnology announces today the acquirement of the ANAVAX virus-like particle (VLP) technology from Select Vaccines Ltd. ANAVAX is a patent-protected VLP technology that can be applied to the prevention of several infectious diseases.

27 Sep 2010

WA teenage death related to swine flu

Teenager Andrew Allan died hours after being sent home from Northam Hospital, Western Australia (WA) with some Paracetamol by a nurse on the 17th September. He was ill with fever and vomiting but was not assessed by a doctor. Health officials now believe his illness was due to swine flu and are urging people to get vaccinated. Nine people have died from swine flu in WA this year.

26 Sep 2010

Key pathway used by malaria parasite to infect human cells identified

Development of an effective vaccine for malaria is a step closer following identification of a key pathway used by the malaria parasite to infect human cells. The discovery, by researchers at The Walter and Eliza Hall Institute in Melbourne, Australia, provides a new vaccine target through which infection with the deadly disease could be prevented.

24 Sep 2010

Global leaders announce new commitments to accelerate progress towards ending malaria deaths

Prominent leaders in global health and development joined several African heads of state at UN Headquarters today to announce new commitments to accelerate progress toward ending deaths from malaria, a disease that claims the lives of more than 850,000 Africans each year.

24 Sep 2010

Eastmont Community Center launches new adolescent immunization awareness initiative

Eastmont Community Center responded today to alarmingly low whooping cough and meningococcal meningitis immunization rates among Latino adolescents by launching a new adolescent immunization awareness initiative. The grassroots campaign aims to educate local Latino families about free or low-cost vaccines available to help protect children against these and other infectious diseases.

24 Sep 2010

Researchers discover new signaling pathway for cell development

Researchers at UCLA's Jonsson Comprehensive Cancer Center have discovered a new cell signaling pathway that controls cell growth and development, a pathway that, when defective, helps promote the formation of several major forms of human cancer, including lymphoma and leukemia.

24 Sep 2010

Researchers discover molecular signature to predict TB infection

Dallas scientists recently discovered a molecular signature in the blood of patients with tuberculosis (TB) that may explain why some people develop an active TB infection, while others exposed to the bacteria which causes the dangerous respiratory virus do not.

24 Sep 2010

ASTMH recommends FDA to include neglected infections of poverty in orphan classification

Today, U.S. scientists committed to finding answers to reducing and eliminating what are known as neglected tropical diseases (NTDs) that plague the world's poorest people in developing countries, urged the FDA to include in its orphan classification the neglected infections of poverty that also affect Americans, and expressed support for stronger relationships with the FDA to ultimately halt these ancient scourges.

24 Sep 2010

Vaccine News and Research

Latest Vaccine News and Research

Trimeris, Roche collaborate to commercialize FUZEON product

Mucosis collaborates with PATH to pursue use of Mimopath technology in diarrhea vaccines

Suicide rates high among middle-aged people

Clinical study results for patient-specific vaccine therapy to treat metastatic melanoma announced

AASLD, TFAH report calls for action to help identify Americans living with HBV, HCV

Many adults skip vaccines because of costs

IAVI investigators awarded grant to examine antibodies that neutralize HIV virus

BMC physicians receive $3M NIH grant to identify TB biomarkers

Sanofi Pasteur signs agreement to acquire VaxDesign

BMC physicians to lead international research collaboration to curb infectious diseases

Condoms can prevent transmission of herpes simplex virus 2: Study

Researchers identify cellular/molecular defect in T cell regulatory pathway

ARTES acquires ANAVAX virus-like particle technology from Select Vaccines

WA teenage death related to swine flu

Key pathway used by malaria parasite to infect human cells identified

Global leaders announce new commitments to accelerate progress towards ending malaria deaths

Eastmont Community Center launches new adolescent immunization awareness initiative

Researchers discover new signaling pathway for cell development

Researchers discover molecular signature to predict TB infection

ASTMH recommends FDA to include neglected infections of poverty in orphan classification

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Vaccine News and Research

Latest Vaccine News and Research

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Newsletters you may be interested in